The effect of systemic leptin administration on aorta smooth muscle responses in diabetic rats

Molecular and Cellular Biochemistry

Volumn 282, Issue 1-2, 2006, Pages 187-191

  Özer, Çiǧdem ^a   Gülen, Şebnem ^a   Dileköz, Ergin ^b   Babül, Aydan ^a   Ercan, Z Sevim ^a  

^a GAZI UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Aorta; Diabetes; Leptin; Streptozotocin

Indexed keywords

ACETYLCHOLINE; GLUCOSE; NITRIC OXIDE; PEPTIDE HORMONE; PHENYLEPHRINE; RECOMBINANT LEPTIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; ISOLATED HEART; MALE; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; MUSCLE RELAXATION; NONHUMAN; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; THORACIC AORTA; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; LEPTIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PHENYLEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

ANIMALIA;

EID: 29644437686     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-1927-0     Document Type: Article

References (31)

1. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer L: Leptin enhaces the calcification of vascular cells: Artery wall as a target of leptin. Circ Res 88(9): 954-960, 2001 11349006
2. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995 7624776
3. Schwartz MW, Seeley RJ, Ampfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98: 1101-1106, 1996 8787671
4. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994 7984236
5. Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F: Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA 93: 1726-1730, 1996 10.1073/ pnas.93.4.1726
6. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002 10.1038/415339a
7. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM: Role of stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297: 240-243, 2002 12114623
8. Seufert J: Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53(1): 152-158, 2004
9. Shek EW, Brands MW, Hall JE: Hypertension Jan;31(1 Pt 2): 409-414, 1998 1:CAS:528:DyaK1cXptF2mtA%3D%3D
10. Dunbar JC, Hu Y, Lu H: Intracerebroventricular leptin, increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46: 2040-2043, 1997 9392493
11. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL: Receptor-mediated regional sympathetic nerve actions by leptin. J Clin Invest 100: 1-9, 1997
12. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM: Periadventitial fat releases a vascular relaxing factor. Faseb J 16(9): 1057-1063, 2002 10.1096/fj.02-0024com
13. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Floreres Riveros JR: Biological action of leptin as an angiogenic factor. Nature 281: 1683-1686, 1998 1:STN:280:DyaK1cvgsVaktA%3D%3D
14. Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, Amati G, Trimarco B: Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 49: 293-297, 2000 10868946
15. Vecchione C, Aretini A, Maffei A, Marino G, Selvetella G, Poulet R, Trimarco V, Frati G, Lembo G: Cooperation between insulin and leptin in the modulatin of vascular tone. Hypertension 42: 166-170, 2003 10.1161/ 01.HYP.0000082806.73530.68
16. Frunhberk G: Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48(4): 903-908, 1999
17. Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 536-546, 2001
18. Francis J, Mohankumar SMJ, Quadri SK: Systemic administration of lipopolysaccharide increases plasma leptin levels. Endocrine 10: 291-295, 1999 10484293
19. Wauters F, Considine VR, van Gaal LF: Human leptin: from an adipocyte hormone to an endocrine mediator. Euro J Endocr 143: 293-311, 2000 1:CAS:528:DC%2BD3cXntVShsr4%3D
20. Hintz K, Aberle NS, Ren J: Insulin resistance induces hyperleptinemia, cardiac contractile dysfunction but not cardiac leptin resistance in ventricular myocytes. Int J Obes Relat Metab Disord Oct 27(10): 1196-1203, 2003 1:CAS:528:DC%2BD3sXnsF2nu7k%3D
21. Kennel WB, Brand N, Skinner JJ, Dauber TR, McNamara PM: The relation of adiposity to blood pressure and development of hypertension: The Framingram study. Ann Intern Med 67: 48-59, 1967
22. Manson JE, Willet WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 333: 677-685, 1995 10.1056/NEJM199509143331101
23. Weber LP, Macleod KM: Influence of streptozotocin diabetes on the alpha-1 adrenoceptor and asssociated G proteins in rat arteries. J Pharmacol Exp Ther 283: 1469-1478, 1997 9400023
24. Fortuno A, Rodriguez A, Gomez-Ambrosi J, Muniz P, Salvador J, Diez J, Fruhbeck G: Leptin inhibitis angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology Sept 143(9): 3555-3560, 2002 1:CAS:528:DC%2BD38XmsVSgu74%3D
25. Carlyle M, Oscar B, Jones JK, John EH: Chronic cardiovascular and renal actions of leptin: Role of adrenergic activity. Hypertension 39(2): 496-501, 2002 10.1161/hy0202.104398
26. Orbay T, Ercan ZS, Seçkin Z, Göksel M: Pharmacological response of endothelium to microvascular temporary clip application. Surg Neurol 33: 192-194, 1990 2107584
27. Ercan ZS, Türker RK: Propranolol enhances acetylcholine-induced relaxation in the various arterial segments of rabbit. Arch Int Pharmacodyn Ther 294: 185-193, 1998
28. Altan M, Karasu C, Özüari A: The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta. Pharm Bioc Behav 33: 519-522, 1989 1:CAS:528:DyaL1MXmtFaktbg%3D
29. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L, Trimarco V, Lembo G: Leptin effect on endothelial nitric oxide is mediated through Akt-Endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51(1): 168-173, 2002 11756337
30. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K: Leptin causes nitric-oxide independent coronary artery vasodilatation in humans. Hypertens Res 26(2): 147-152, 2003 10.1291/hypres.26.147
31. Kimura K, Tsuda K, Baba A, Kowabe T, Boh-oka S, Ibata M, Moriwaki C, Hano T, Nishio I: Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 273: 745-749, 2000 10.1006/bbrc.2000.3005